Channelpedia

PubMed 16796904


Referenced in Channelpedia wiki pages of: none

Automatically associated channels: HCN3 , HCN4



Title: [Electrophysiological effects of hyperpolarization activated cyclic nucleotide gated channel 4 overexpression in neonatal cardiomyocytes mediated by recombinant adenovirus]

Authors: Ji-wen Li, Ji-hong Guo, Ping Zhang, Chun Li, Yuan-wei Liu, Chun-yan Zhou

Journal, date & volume: Zhonghua Yi Xue Za Zhi, 2006 May 23 , 86, 1332-6

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/16796904


Abstract
To explore the electrophysiological effects of hyperpolarization activated cyclic nucleotide gated channel 4 (HCN4) overexpression in rat neonatal cardiomyocytes mediated by recombinant adenovirus.Ventricular cardiomyocytes were obtained from 20 neonatal rats. Recombinant adenovirus carrying HCN4 gene, AdHCN4, a dominant isoform of hyperpolarization activated cyclic nucleotide gated cation channel gene in cardiac transduction system, was constructed and used to transfect the neonatal rat ventricular cardiomyocytes. Untransfected cardiomyocytes were used as controls. RT-PCR and immunofluorescence cytochemistry were used to detect the HCN4 mRNA and protein expression. The electrophysiological characteristics of infected cardiomyocytes were studied by patch clamp.The mRNA and protein expression levels of HCN4 in AdHCN4 infected cardiomyocytes were both markedly higher than those of the control cardiomyocytes. AdHCN4 caused a significant increase in The spontaneous rate in the transfected cardiomyocytes was 92.5 + 7.4 bpm, significantly higher than that of the control cells (68.9 + 6.2 bpm, P < 0.05). Patch clamp experiments showed that the pacemaker current density in the AdHCN4 infected cardiomyocytes was 115.7 + 7.8 pA/pF, significantly higher than that of the untransfected cells (7.2 + 0.6 pA/pF, P < 0.05).Overexpression of HCN4 can enhance the autorhythmicity of neonatal cardiomyocytes and significantly increase the spontaneous beat rate. HCN4 channel gene may represent a candidate gene in gene therapy for bradycardia diseases.